Characterization of Sulfobutyl Ether Beta-cyclodextrin Binary and Ternary Inclusion Complexes of Loratadine

IF 0.4 Q4 PHARMACOLOGY & PHARMACY Asian Journal of Pharmaceutics Pub Date : 2020-11-28 DOI:10.22377/ajp.v14i4.3832
K. Ramesh
{"title":"Characterization of Sulfobutyl Ether Beta-cyclodextrin Binary and Ternary Inclusion Complexes of Loratadine","authors":"K. Ramesh","doi":"10.22377/ajp.v14i4.3832","DOIUrl":null,"url":null,"abstract":"Background: Poor solubility and dissolution of drugs are major hindering factors in the development of their oral dosage forms with acceptable bioavailability. Of the various approaches, employing amorphous form of drugs is frequently utilized to develop drug products. Inclusion complexation is widely employed to prepare stable and fast dissolving forms of drug compounds. Objective: The objective of this work was to characterize the inclusion complexes of a poorly soluble drug loratadine prepared by employing sulfobutyl ether beta-cyclodextrin (SBE7-β-CD) in the presence or absence of water-soluble polymers. The investigation aims to find out the effect of water-soluble polymers on complexation efficiency and enhanced dissolution of the ternary complexes (TC). Materials and Methods: Binary and ternary inclusion complexes of loratadine in SBE7-β-CD were prepared by freeze drying method. TC were prepared using gelucire (50/13) and soluplus as the auxiliary hydrophilic polymers and formulated as tablets. The prepared complexes are evaluated by X-ray diffraction, differential scanning calorimetry, Fourier-transform infrared, and dissolution study. Results: X-ray diffraction and DSC studies confirmed that inclusion complexation converted crystalline loratadine into an amorphous form enhancing its dissolution. Gelucire and soluplus were effective in promoting dissolution and forming complexes of higher efficiency at a low concentration of 0.3% w/v and 0.6%w/v, respectively. The formulated tablets of inclusion complexes exhibited satisfactory pharmaceutical properties. Conclusion: Employing ternary inclusion complexes prepared by utilizing gelucire (50/13) and soluplus is a promising approach to develop fast dissolving formulations of poorly soluble drugs such as loratadine.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2020-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/ajp.v14i4.3832","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Poor solubility and dissolution of drugs are major hindering factors in the development of their oral dosage forms with acceptable bioavailability. Of the various approaches, employing amorphous form of drugs is frequently utilized to develop drug products. Inclusion complexation is widely employed to prepare stable and fast dissolving forms of drug compounds. Objective: The objective of this work was to characterize the inclusion complexes of a poorly soluble drug loratadine prepared by employing sulfobutyl ether beta-cyclodextrin (SBE7-β-CD) in the presence or absence of water-soluble polymers. The investigation aims to find out the effect of water-soluble polymers on complexation efficiency and enhanced dissolution of the ternary complexes (TC). Materials and Methods: Binary and ternary inclusion complexes of loratadine in SBE7-β-CD were prepared by freeze drying method. TC were prepared using gelucire (50/13) and soluplus as the auxiliary hydrophilic polymers and formulated as tablets. The prepared complexes are evaluated by X-ray diffraction, differential scanning calorimetry, Fourier-transform infrared, and dissolution study. Results: X-ray diffraction and DSC studies confirmed that inclusion complexation converted crystalline loratadine into an amorphous form enhancing its dissolution. Gelucire and soluplus were effective in promoting dissolution and forming complexes of higher efficiency at a low concentration of 0.3% w/v and 0.6%w/v, respectively. The formulated tablets of inclusion complexes exhibited satisfactory pharmaceutical properties. Conclusion: Employing ternary inclusion complexes prepared by utilizing gelucire (50/13) and soluplus is a promising approach to develop fast dissolving formulations of poorly soluble drugs such as loratadine.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
氯雷他定磺基丁基醚-环糊精二元和三元包合物的表征
背景:药物溶解度和溶出度差是开发具有可接受生物利用度的口服剂型的主要阻碍因素。在各种方法中,使用无定形形式的药物经常用于开发药物产品。包合络合被广泛用于制备稳定且快速溶解的药物化合物。目的:本工作的目的是在存在或不存在水溶性聚合物的情况下,用磺丁基醚-β-环糊精(SBE7-β-CD)制备难溶性药物氯雷他定的包合物。本研究旨在了解水溶性聚合物对三元配合物(TC)络合效率和增强溶解的影响。材料与方法:采用冷冻干燥法制备氯雷他定与SBE7-β-CD的二元和三元包合物。TC是用凝胶(50/13)和soluplus作为辅助亲水聚合物制备的,并配制成片剂。通过X射线衍射、差示扫描量热法、傅立叶变换红外光谱和溶解研究对制备的配合物进行了评价。结果:X射线衍射和DSC研究证实,包合物将结晶氯雷他定转化为无定形形式,增强了其溶解性。凝胶和soluplus在0.3%w/v和0.6%w/v的低浓度下分别有效地促进溶解并形成更高效的络合物。所配制的包合物片剂表现出令人满意的药物性能。结论:利用凝胶(50/13)和soluplus制备的三元包合物是开发氯雷他定等难溶性药物的快溶制剂的一种很有前途的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Asian Journal of  Pharmaceutics
Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
47
期刊介绍: Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences
期刊最新文献
A Design of Experiment-based Approach for the Formulation Development and Evaluation of Repaglinide Transdermal Patch Using Natural Polymers Modification of Human Behavior due to Coronavirus Outbreak: A Brief Study on Current Scenario Formulation and Evaluation of Sustained Release Bilayer Tablets of Losartan Potassium Bioanalytical Method Development and Validation of Empagliflozin by LC–MS/MS Method and Quantitative Estimation of Drug Concentration in Human Plasma Formulation and Evaluation of Antidiabetic Polyherbal Tablets
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1